Emerging evidence in NPC reveals that USP10 inhibition disrupts G3BP1 deubiquitination, mechanistically linked to cisplatin chemoresistance and metastatic dissemination9. The gene discussed is G3BP1; the disease is nasopharyngeal carcinoma.